Australia markets open in 4 hours 14 minutes

Amrutanjan Health Care Limited (AMRUTANJAN.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
750.05-8.75 (-1.15%)
At close: 03:30PM IST
Currency in INR

Valuation measures4

Market cap (intra-day) 21.71B
Enterprise value 19.62B
Trailing P/E 48.45
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.17
Price/book (mrq)7.52
Enterprise value/revenue 4.66
Enterprise value/EBITDA 28.78

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 318.51%
S&P500 52-week change 326.24%
52-week high 3804.00
52-week low 3563.90
50-day moving average 3720.53
200-day moving average 3640.24

Share statistics

Avg vol (3-month) 375.13k
Avg vol (10-day) 345.46k
Shares outstanding 528.89M
Implied shares outstanding 629.18M
Float 84.27M
% held by insiders 154.65%
% held by institutions 17.36%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 45.6
Forward annual dividend yield 40.75%
Trailing annual dividend rate 34.60
Trailing annual dividend yield 30.61%
5-year average dividend yield 40.57
Payout ratio 429.68%
Dividend date 3N/A
Ex-dividend date 420 Feb 2024
Last split factor 22:1
Last split date 313 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 10.68%
Operating margin (ttm)11.57%

Management effectiveness

Return on assets (ttm)7.85%
Return on equity (ttm)15.53%

Income statement

Revenue (ttm)4.21B
Revenue per share (ttm)145.18
Quarterly revenue growth (yoy)26.50%
Gross profit (ttm)N/A
EBITDA 518.11M
Net income avi to common (ttm)449.73M
Diluted EPS (ttm)15.47
Quarterly earnings growth (yoy)7.60%

Balance sheet

Total cash (mrq)2.11B
Total cash per share (mrq)73.02
Total debt (mrq)17.28M
Total debt/equity (mrq)0.60%
Current ratio (mrq)4.23
Book value per share (mrq)99.69

Cash flow statement

Operating cash flow (ttm)279.11M
Levered free cash flow (ttm)205.03M